The CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel-Influenza A/H7 Assay has received an emergency use authorization from the FDA. The test, which will run on the Applied Biosystems 7500 Fast Dx Real-Time PCR platform, is intended to identify the presence of influenza A virus subtype H7N9 in patients exhibiting symptoms of respiratory infection. H7N9 is an avian strain of influenza that has surfaced in Asia, infecting more than 100 people. At least 20 patients have died.

Related Summaries